Paul Tudor Jones Ab Cellera Biologics Inc. Transaction History

Tudor Investment Corp Et Al

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.73 - $4.73 $398,347 - $690,177	145,915 Added 160.82%	236,649 $700,000
Q1 2024 May 15, 2024	BUY	$4.29 - $5.97 $389,248 - $541,681	90,734 New	90,734 $411,000
Q3 2023 Nov 15, 2023	BUY	$4.6 - $7.95 $8,546 - $14,771	1,858 Added 10.18%	20,105 $92,000
Q2 2023 Aug 14, 2023	BUY	$5.66 - $7.59 $990 - $1,328	175 Added 0.97%	18,247 $117,000
Q1 2023 May 15, 2023	BUY	$7.31 - $11.18 $17,719 - $27,100	2,424 Added 15.49%	18,072 $136,000
Q4 2022 Feb 14, 2023	BUY	$9.48 - $14.52 $3,810 - $5,837	402 Added 2.64%	15,648 $159,000
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $45,788 - $68,085	4,977 Added 48.47%	15,246 $151,000
Q2 2022 Aug 15, 2022	SELL	$5.72 - $10.65 $62,004 - $115,446	-10,840 Reduced 51.35%	10,269 $109,000
Q1 2022 May 16, 2022	BUY	$7.46 - $14.14 $157,473 - $298,481	21,109 New	21,109 $206,000
Q4 2021 Feb 14, 2022	SELL	$12.99 - $17.73 $196,421 - $268,095	-15,121 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$14.85 - $21.34 $959,354 - $1.38 Million	-64,603 Reduced 81.03%	15,121 $303,000
Q2 2021 Aug 16, 2021	BUY	$20.19 - $34.17 $1.61 Million - $2.72 Million	79,724 New	79,724 $1.75 Million

153

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $787M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.